In vitro mitochondrial apoptosis of melanoma cells via immature Poncirus trifoliata fruit extract

S-Y Kim1, I H Choi, M J Han

  • 1Research Institute of Clinical Medicine of Jeonbuk National University - Biomedical Research  Institute of Jeonbuk National University Hospital, Jeonju, Korea. children@jbnu.ac.kr.

Abstract

Insights

Immature Poncirus trifoliata fruit extract effectively inhibits melanoma cell growth by inducing apoptosis via mitochondrial pathways. This study highlights its potential as a natural therapeutic for melanoma.

Area of Science:

  • Phytotherapy
  • Cancer Research
  • Molecular Biology

Background:

  • Poncirus trifoliata (P. trifoliata) fruits possess phytotherapeutic properties influenced by maturity.
  • The precise mechanisms underlying P. trifoliata's effects, particularly in cancer, are not fully understood.
  • This study focuses on the anti-cancer potential of immature P. trifoliata fruit extract against melanoma.

Purpose of the Study:

  • To investigate the effects of immature P. trifoliata fruit extract on B16 melanoma cells.
  • To elucidate the molecular mechanisms by which the extract inhibits melanoma cell growth and progression.

Main Methods:

  • Cell viability was assessed using MTT assays.
  • Cell cycle, apoptosis, migration, invasion, and mitochondrial function were evaluated using flow cytometry, Western blotting, and specific assays.
  • The PI3K/AKT/p21 pathway was analyzed.

Main Results:

  • Methanol extract of immature P. trifoliata (MEPT) significantly inhibited B16 cell viability, migration, and invasion in a dose- and time-dependent manner.
  • MEPT induced G1 cell cycle arrest and apoptosis by modulating Bax, Apaf-1, and Bcl-2 expression.
  • The extract disrupted mitochondrial membrane potential and activated the PI3K/AKT/p21 pathway.

Conclusions:

  • Immature P. trifoliata extract demonstrates anti-melanoma activity by inducing apoptosis through mitochondrial pathways.
  • The findings suggest that MEPT is a promising candidate for further development as a melanoma therapeutic agent.